Metrikler
Yayın
49
Açık Erişim
5
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (43)
SCI-E, SSCI, AHCI (40)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (1)
Scopus (42)
TRDizin (3)
2022
20221. Endothelial nitric oxide synthase G894T, intron 4 VNTR, and T786C polymorphisms in retinopathy of prematurity
Tekkeşin F., Yurdakok M., GÜMÜŞ E., BABAOĞLU M. Ö., Bozkurt A., Caliskan Kadayifcilar S., et al.
Journal of Neonatal-Perinatal Medicine
, cilt.15, sa.2, ss.249-255, 2022 (Scopus)
2022
20222. The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension
Tanrikulu F. P., BABAOĞLU M. Ö., ÇAKIR B., BOZKURT A., Guven G. S.
CUKUROVA MEDICAL JOURNAL
, cilt.47, sa.3, ss.1015-1023, 2022 (ESCI, TRDizin)
2017
20173. Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease
Goktas M. T., KARACA R. O., KALKISIM S., Cevik L., KILIC L., AKDOĞAN A., et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.121, sa.4, ss.266-271, 2017 (SCI-Expanded, Scopus)
2017
20174. EFFECTS OF GENETIC POLYMORPHISMS OF MULTI DRUG RESISTANCE PROTEIN (MDR1) ON LANSOPRAZOLE METABOLISM IN PEDIATRIC PATIENTS
Karaca R. O., Kalkisim S., GÜMÜŞ E., Goktas M. T., YÜCE A., YAŞAR Ü., et al.
DRUG METABOLISM AND PHARMACOKINETICS
, cilt.32, sa.1, 2017 (SCI-Expanded, Scopus)
2016
20165. Investigation of 1377C/T polymorphism of the Toll-like receptor 3 among patients with chronic hepatitis B
Goktas E. F., Bulut C., Goktas M. T., Ozer E. K., Karaca R. O., Kinikli S., et al.
CANADIAN JOURNAL OF MICROBIOLOGY
, cilt.62, sa.7, ss.617-622, 2016 (SCI-Expanded, Scopus)
2016
20166. mu-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample
GÜREL Ş. C., AYHAN Y., Karaaslan C., Akel H., KARACA R. O., BABAOĞLU M. Ö., et al.
TURK PSIKIYATRI DERGISI
, cilt.27, sa.2, ss.75-83, 2016 (SSCI, Scopus, TRDizin)
2016
20167. Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine
YAGCIOGLU A. E., Yoca G., AYHAN Y., KARACA R. O., Cevik L., MÜDERRİSOĞLU A., et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
, cilt.36, sa.3, ss.257-261, 2016 (SCI-Expanded, Scopus)
2015
20158. Lower CYP2C9 activity in Turkish patients with Beh double dagger et's disease compared to healthy subjects: a down-regulation due to inflammation?
Goktas M. T., Hatta F., KARACA O., KALKISIM S., KILIC L., AKDOĞAN A., et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.71, sa.10, ss.1223-1228, 2015 (SCI-Expanded, Scopus)
2015
20159. Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter
Zoto T., KILIÇKAP S., YAŞAR Ü., ÇELİK İ., BOZKURT A., BABAOĞLU M. Ö.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.116, sa.4, ss.354-360, 2015 (SCI-Expanded, Scopus)
2015
201510. Association between ADH1C and ALDH2 polymorphisms and alcoholism in a Turkish sample
AYHAN Y., GÜREL Ş. C., KARACA O., ZOTO T., HAYRAN M., BABAOGLU M., et al.
NORDIC JOURNAL OF PSYCHIATRY
, cilt.69, sa.3, ss.233-239, 2015 (SCI-Expanded, SSCI, Scopus)
2015
201511. Quantitative Characterization of Magnetic Mobility of Nanoparticle in Solution-Based Condition
RODOPLU D., BOYACI İ. H., BOZKURT A. G., EKSI H., Zengin A., Tamer U., et al.
CURRENT PHARMACEUTICAL DESIGN
, cilt.21, sa.37, ss.5389-5400, 2015 (SCI-Expanded, Scopus)
2014
201412. INVESTIGATION OF THE ROLE OF ALLELIC VARIANTS OF MULTIDRUG RESISTANCE GENE (MDR1) ON CLOZAPINE RELATED LEUKOPENIA/AGRANULOCYTOSIS
ANIL YAĞCIOĞLU A. E., YOCA G., Karaca R. O., ÇEVİK L., BABAOĞLU M. Ö., AYHAN Y., et al.
SCHIZOPHRENIA RESEARCH
, cilt.153, 2014 (SCI-Expanded, SSCI, Scopus)
2013
201313. Ocular Pharmacokinetics, Safety and Efficacy of Intracameral Moxifloxacin 0.5% Solution in a Rabbit Model
Akova Y., ASENA L., Goktas M., BOZKURT A., YAŞAR Ü., Karabay G., et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
, cilt.54, sa.15, 2013 (SCI-Expanded, Scopus)
2013
201314. Ocular Pharmacokinetics, Safety and Efficacy of Intracameral Moxifloxacin 0.5% Solution in a Rabbit Model
ASENA L., Akova Y. A., GÖKTAŞ M. T., BOZKURT A., YAŞAR Ü., Karabay G., et al.
CURRENT EYE RESEARCH
, cilt.38, sa.4, ss.472-479, 2013 (SCI-Expanded, Scopus)
2012
201215. Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood
GÜMÜŞ E., Karaca O., BABAOĞLU M. Ö., BAYSOY G., Balamtekin N., DEMİR H., et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.68, sa.5, ss.629-636, 2012 (SCI-Expanded, Scopus)
2011
201116. Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients
YAŞAR Ü., SAİN GÜVEN G., Yardimci Y., KILIÇARSLAN A., BABAOĞLU M. Ö., BOZKURT A.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.109, sa.2, ss.73-77, 2011 (SCI-Expanded, Scopus)
2011
201117. CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia
Balibey H., Basoglu C., Lundgren S., BABAOĞLU M. Ö., YAŞAR Ü., Herken H., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, cilt.21, sa.2, ss.93-99, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
201118. Functional Effects of Endothelial Nitric Oxide Synthase Genetic Polymorphisms on Haemorheological Parameters in Healthy Human Individuals
BABAOĞLU M. Ö., Dikmenoglu N., Ileri-Gurel E., Seringec N., Zoto T., YAŞAR Ü., et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.108, sa.3, ss.171-176, 2011 (SCI-Expanded, Scopus)
2008
200819. Pharmacotherapy resistance in patients undergoing resective epilepsy surgery due to hippocampal sclerosis is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene
Yasar U., Babaoglu M. O., Dericioglu N., Bal B., Bozkurt A., Saygi S.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
, cilt.22, ss.51, 2008 (SCI-Expanded, Scopus)
2007
200720. Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth
GÜNCÜ G. N., ÇAĞLAYAN F., Dincel A., Bozkurt A., ÖZMEN F., KARABULUT E.
AUSTRALIAN DENTAL JOURNAL
, cilt.52, sa.4, ss.295-299, 2007 (SCI-Expanded, Scopus)
2007
200721. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model
Yagci R., Oflu Y., Dincel A., Kaya E., Yagci S., Bayar B., et al.
EYE
, cilt.21, sa.7, ss.990-994, 2007 (SCI-Expanded, Scopus)
2007
200722. Lens concentration of ofloxacin and lomefloxacin in an experimental endophthalmitis model
Yagci R., Oflu Y., Yagci S., Dincel A., Kaya E., Duman S., et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
, cilt.68, sa.3, ss.184-190, 2007 (SCI-Expanded, Scopus)
2007
200723. Effect of ocular compression on intraocular penetration of systemic ofloxacin
Ugurbas S. H., Can M., Koksal M., Dincel A., Bozkurt A., Bayar B.
ADVANCES IN THERAPY
, cilt.24, sa.2, ss.394-401, 2007 (SCI-Expanded, Scopus)
2007
200724. Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients
Elkiran T., Harputhioglu H., Yasar U., Babaoglu M. O., Dincel A. K., Altundag K., et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
, cilt.29, sa.1, ss.27-32, 2007 (SCI-Expanded, Scopus)
2006
200625. Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth
Guncu G. N., Caglayan F., Dincel A., Bozkurt A., Saygi S., Karabulut E.
JOURNAL OF PERIODONTOLOGY
, cilt.77, sa.12, ss.2005-2010, 2006 (SCI-Expanded, Scopus)
2006
200626. Inhibitory effect of 5-fluorouracil on cytochrome P4502C9 activity in cancer patients
Gunes A., Coskun U., Boruban C., Gunel N., Babaoglu M., Sencan O., et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.98, sa.2, ss.197-200, 2006 (SCI-Expanded, Scopus)
2005
200527. Association of the ABCB1 3435C > T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists
Babaoglu M., Bayar B., Aynacioglu A., Kerb R., Abali H., Celik I., et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS
, cilt.78, sa.6, ss.619-626, 2005 (SCI-Expanded, Scopus)
2004
200428. Functional impact of CYP2C*5, CYP2C9*6, CYP2C9*8, and CYP2C9*11 in vivo among black Africans
Allabi A., Gala J., Horsmans Y., Babaoglu M., Bozkurt A., Heusterspreute M., et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS
, cilt.76, sa.2, ss.113-118, 2004 (SCI-Expanded, Scopus)
2004
200429. Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report
Babaoglu M., Karadag O., Saikawa Y., Altundag K., Elkiran T., Yasar U., et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.60, sa.6, ss.455-456, 2004 (SCI-Expanded, Scopus)
2004
200430. CYP2C9 genetic variants and losartan oxidation in a Turkish population
Babaoglu M., Yasar U., Sandberg M., Eliasson E., Dahl M., Kayaalp S., et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.60, sa.5, ss.337-342, 2004 (SCI-Expanded, Scopus)
2004
200431. Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population
Babaoglu M., Ocal T., Bayar B., Kayaalp S., Bozkurt A.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.59, sa.12, ss.875-877, 2004 (SCI-Expanded, Scopus)
2004
200432. 5-fluorouracil-induced coronary spasm: May inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?
Karadag O., Babaoglu M., Altundag K., Elkiran T., Yasar U., Bozkurt A.
ONCOLOGY
, cilt.66, sa.6, ss.510-511, 2004 (SCI-Expanded, Scopus)
2000
200033. Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans
Cekic O., Batman C., Yasar U., Basci N. E., Zilelioglu O., Bozkurt A.
BRITISH JOURNAL OF OPHTHALMOLOGY
, cilt.84, sa.9, ss.1061-1063, 2000 (SCI-Expanded, Scopus)
2000
200034. The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin
Ozturk F., Kurt E., Inan U., Kortunay S., Ilker S., Basci N. E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.204, ss.97-100, 2000 (SCI-Expanded, Scopus)
2000
200035. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats
Erdem A., Gundogan N., Usubutun A., Kilinc K., Erdem S., Kara A., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, cilt.15, sa.8, ss.1175-1182, 2000 (SCI-Expanded, Scopus)
2000
200036. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes
Ozturk F., Kurt E., Inan U., Kortunay S., Ilker S., Basci N. E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS
, cilt.204, ss.91-95, 2000 (SCI-Expanded, Scopus)
2000
200037. The pharmacokinetics and effects of diltiazem in rabbits
Oruc S., Orhan D., Orhan M., Irkec M., Basci N. E., Barun S., et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
, cilt.10, sa.1, ss.46-50, 2000 (SCI-Expanded, Scopus)
1999
199938. Penetration of topical ciprofloxacin by presoaked medicated soft contact lenses
Kalayci D., Basci N. E., Kortunay S., Hasiripi H., Bozkurt A.
CLAO Journal
, cilt.25, sa.3, ss.182-184, 1999 (Scopus)
1998
199839. Optimization of the separation of β-blockers in HPLC
Basci N. E., Temizer A., Bozkurt A., Isimer A.
Journal de Pharmacie de Belgique
, cilt.53, sa.3, ss.156, 1998 (SCI-Expanded, Scopus)
1994
199440. Correlation Between the Metabolic Ratios of Debrisoquine and Metoprolol in Turkish Subjects
Basci N. E., Bozkurt A., Isimer A., Kayaalp S.
Pharmacology & Toxicology
, cilt.75, sa.1, ss.62-64, 1994 (SCI-Expanded, Scopus)
1994
199441. S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.
Basci N. E., Brosen K., Bozkurt A., Isimer A., Sayal A., Kayaalp S.
British Journal of Clinical Pharmacology
, cilt.38, sa.5, ss.463-465, 1994 (SCI-Expanded, Scopus)
1990
199042. Comparison of colorimetric and high-performance liquid chromatographic determination of sulphamethoxazole and acetylsulphamethoxazole
Basci N. E., Bozkurt A., Kayaalp S., Isimer A.
Journal of Chromatography B: Biomedical Sciences and Applications
, cilt.527, ss.174-181, 1990 (SCI-Expanded)
1990
199043. N-ACETYLATION PHENOTYPING WITH SULFADIMIDINE IN A TURKISH POPULATION
BOZKURT A., BASCI N. E., KALAN S., TUNCER M., KAYAALP S.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.38, sa.1, ss.53-56, 1990 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2010
20101. Relationship between genetic polymorphisms of multidrug resistance gene MDR1 (ABCB1) and clearance of 99mTc-MIBI
Kapulu-Akca C., Goktas M., Babaoglu M. O., Altundag K., Yasar U., Celik I., et al.
23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Avusturya, 9 - 13 Ekim 2010, cilt.37, (Özet Bildiri)
2010
20102. Association of serotonin transporter gene (SLC6A4) polymorphisms with alcohol dependence in a Turkish population
KARACA O. R., BABAOĞLU M. Ö., YAŞAR Ü., AYHAN Y., GÜREL Ç. S., DILBAZ N., et al.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.255-256, (Özet Bildiri)
2006
20063. Drug transporter gene MDR1 polymorphism C3435T may explain colchicine nonresponsiveness in familial Mediterranean fever
Tufan A., Babaoglu M., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.100, (Özet Bildiri)
2005
20054. Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.
Elkiran E., Altundag K., Babaoglu M., Yasar U., Ozisik Y., Guler N., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2004
20045. Effects of CYP2C9*5,*6,*8 and *11 polymorphisms on losartan oxidation among black Africans
Allabi A., Gala J., Horsmans Y., Babaoglu M., Bozkurt A., Heusterspreute M., et al.
8th World Congress of Clinical Pharmacology and Therapeutics, Brisbane, Avustralya, 1 - 06 Ağustos 2004, cilt.31, (Özet Bildiri)
2004
20046. Tamoxifen inhibits cytochrome P4502C9 activity: A possible mechanism for tamoxifen-warfarin interaction.
Boruban M., Babaoglu M., Sencan O., Bozkurt A., Yasar U.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)